STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
NeuroVive Pharmaceutical AB (STO:NVP):
Third Quarter (1 Jul. 2014 – 30 Sep. 2014)
· Net revenues were SEK 7,152,000 (0) and other operating income was SEK 2,000 (201,000).
Help employers find you! Check out all the jobs and post your resume.
NeuroVive Pharmaceutical AB (STO:NVP):
Third Quarter (1 Jul. 2014 – 30 Sep. 2014)
· Net revenues were SEK 7,152,000 (0) and other operating income was SEK 2,000 (201,000).
Help employers find you! Check out all the jobs and post your resume.
